Search research articles
Contact Us
Filters
Showing results (111-120 of 269) with videos related to
Page
of 27
Sort By:
BMC Cancer
|
March 20, 2014
Ion Prostate Irradiation (IPI) - a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique
Gregor Habl, Gencay Hatiboglu, Lutz Edler, et al.
Scientific Reports
|
November 15, 2024
The effect of chemotherapy regimens in male germ cell tumors on the development of primary hypogonadism
Analena Handke, Marla Geller-von Bargen, Aykhan Isgandarov, et al.
Disease Markers
|
May 4, 2018
Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data
Henning Reis, Ulrich Krafft, Christian Niedworok, et al.
The Prostate
|
June 8, 2025
Real-World Overall Survival Comparison of Enzalutamide and Abiraterone In First- and Second-Line Setting of Metastatic Castration-Resistant Prostate Cancer
András Horváth, Celia Blasszauer, Ida Komka, et al.
World Journal of Urology
|
December 28, 2013
The impact of type 2 diabetes on the outcome of localized renal cell carcinoma
Thomas Höfner, Martin Zeier, Gencay Hatiboglu, et al.
European Urology Oncology
|
March 22, 2021
Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment: A Systematic Review
Andrea Farolfi, Boris Hadaschik, Freddie C Hamdy, et al.
Urologic Oncology
|
June 16, 2014
Phenotypic drug screening and target validation for improved personalized therapy reveal the complexity of phenotype-genotype correlations in clear cell renal cell carcinoma
Meike Schneider, Julia Schüler, Rouven Höfflin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2018
Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets
Stephan Lang, Kirsten Bruderek, Cordelia Kaspar, et al.
Urologia Internationalis
|
November 10, 2021
Retrograde Pyelography in the Presence of Urothelial Bladder Cancer Does Not Affect the Risk of Upper Tract Urothelial Cancer: A Retrospective Analysis of a Single-Centre Cohort
Lukas Püllen, Cordelia Kaspar, Andrej Panic, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 2, 2022
Unspecific <sup>18</sup>F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer
Robert Seifert, Tugce Telli, Marcel Opitz, et al.
Page
of 27
Search research articles
Search
Showing results (111-120 of 269) with videos related to
Sort By:
Page
of 27
BMC Cancer
|
March 20, 2014
Ion Prostate Irradiation (IPI) - a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique
Gregor Habl, Gencay Hatiboglu, Lutz Edler, et al.
Scientific Reports
|
November 15, 2024
The effect of chemotherapy regimens in male germ cell tumors on the development of primary hypogonadism
Analena Handke, Marla Geller-von Bargen, Aykhan Isgandarov, et al.
Disease Markers
|
May 4, 2018
Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data
Henning Reis, Ulrich Krafft, Christian Niedworok, et al.
The Prostate
|
June 8, 2025
Real-World Overall Survival Comparison of Enzalutamide and Abiraterone In First- and Second-Line Setting of Metastatic Castration-Resistant Prostate Cancer
András Horváth, Celia Blasszauer, Ida Komka, et al.
World Journal of Urology
|
December 28, 2013
The impact of type 2 diabetes on the outcome of localized renal cell carcinoma
Thomas Höfner, Martin Zeier, Gencay Hatiboglu, et al.
European Urology Oncology
|
March 22, 2021
Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment: A Systematic Review
Andrea Farolfi, Boris Hadaschik, Freddie C Hamdy, et al.
Urologic Oncology
|
June 16, 2014
Phenotypic drug screening and target validation for improved personalized therapy reveal the complexity of phenotype-genotype correlations in clear cell renal cell carcinoma
Meike Schneider, Julia Schüler, Rouven Höfflin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2018
Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets
Stephan Lang, Kirsten Bruderek, Cordelia Kaspar, et al.
Urologia Internationalis
|
November 10, 2021
Retrograde Pyelography in the Presence of Urothelial Bladder Cancer Does Not Affect the Risk of Upper Tract Urothelial Cancer: A Retrospective Analysis of a Single-Centre Cohort
Lukas Püllen, Cordelia Kaspar, Andrej Panic, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 2, 2022
Unspecific <sup>18</sup>F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer
Robert Seifert, Tugce Telli, Marcel Opitz, et al.
Page
of 27